Search Submit
Close

Editor-in-Chief of Clinical Medicine and Therapeutics

Dr. George Perry is a world-renowned neuroscientist and Dean of the College of Sciences and Professor of Biology at the University of Texas at San Antonio. He earned a B.A. in zoology from the University of California, Santa Barbara and a Ph.D. in marine biology from the Scripps Institution of Oceanography. He received a postdoctoral fellowship in the Department of Cell Biology at Baylor College of Medicine. In 1982, he joined the faculty of Case Western Reserve University, where he currently holds an adjunct appointment. Dr. Perry relocated to San Antonio in 2006 to assume his current position of Dean of the College of Sciences at UTSA.

Dr. George Perry is recognized internationally for his work in the field of Alzheimer's disease research, particularly in the area of oxidative stress. He has been cited over 65,000 times and is recognized as a Thompson-Reuters highly cited researcher. Dr. Perry is editor for numerous journals and is editor-in-chief for the Journal of Alzheimer's Disease.

He is a fellow of the American Association for the Advancement of Sciences, the Microscopy Society of America, the Texas Academy of Sciences, past-president of the American Association of Neuropathologists and the Southwestern and Rocky Mountain division of AAAS, a member of the Dana Alliance for Brain Initiatives, and a Fulbright Specialist. He is a Foreign Correspondent Member of the Spanish Royal Academy of Sciences, the Academy of Science Lisbon, and a Foreign Member of the Mexican National Academy of Sciences. He is also a recipient of the National Plaque of Honor from the Republic of Panama Ministry of Science and Technology.

Dr. Perry’s studies are focused on the mechanism of formation and physiological consequences of the cytopathology of Alzheimer disease. The lab has shown that oxidative damage is the initial cytopathology in Alzheimer disease. They are working to determine the sequence of events leading to neuronal oxidative damage and the source of the increased oxygen radicals. His current studies focus on the mechanism for RNA-based redox metal binding ,consequences of RNA oxidation on protein synthesis rate and fidelity, the role of redox active metals in mediating prooxidant and antioxidant properties, signal transduction pathways altered in Alzheimer disease that allow neurons to evade apoptosis and the mechanism of phosphorylation control of oxidative damage to neurofilament proteins.

Dr. Perry is distinguished as one of the top Alzheimer’s disease researchers with over 900 publications, one of the top 100 most-cited scientists in neuroscience and behavior. Perry has been cited over 40,000 times (H=101) and is recognized as an ISI highly cited researcher. Dr. Perry is editor for numerous journals and is editor-in-chief for the Journal of Alzheimer's Disease.

Prof. George Perry
Editor-in-Chief
Clinical Medicine and Therapeutics
Dean and Professor
College of Sciences, University of Texas at San Antonio, USA